U.S., March 19 -- An application to own the trademark for 'SARCLISA SIMPRE' has been filed on Dec. 12, 2023.
Owner(s):
Sanofi; 46 avenue de la Grande Armée, , FRANCE
Goods and/or Services:
For: Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment of multiple myeloma
Class(es): 005, 006, 018, 044, 046, 051, 052
Mark Drawing Type: 4 - STANDARD CHARACTER MARK
https://eog-tmng.uspto.gov/#/issueDate=2025-03-18&serialNumber=98310452
Disclaimer: Curated by HT Syndication....